title: Sequences in gibbon ape leukemia virus envelope that confer sensitivity to HIV-1 accessory protein Vpu.
abstract: HIV-1 efficiently forms pseudotyped particles with many gammaretrovirus glycoproteins, such as Friend murine leukemia virus (F-MLV) Env, but not with the related gibbon ape leukemia virus (GaLV) Env or with a chimeric F-MLV Env with a GaLV cytoplasmic tail domain (CTD). This incompatibility is modulated by the HIV-1 accessory protein Vpu. Because the GaLV Env CTD does not resemble tetherin or CD4, the well-studied targets of Vpu, we sought to characterize the modular sequence in the GaLV Env CTD required for this restriction in the presence of Vpu. Using a systematic mutagenesis scan, we determined that the motif that makes GaLV Env sensitive to Vpu is INxxIxxVKxxVxRxK. This region in the CTD of GaLV Env is predicted to form a helix. Mutations in the CTD that would break this helix abolish sensitivity to Vpu. Although many of these positions can be replaced with amino acids with similar biophysical properties without disrupting the Vpu sensitivity, the final lysine residue is required. This Vpu sensitivity sequence appears to be modular, as the unrelated Rous sarcoma virus (RSV) Env can be made Vpu sensitive by replacing its CTD with the GaLV Env CTD. In addition, F-MLV Env can be made Vpu sensitive by mutating two amino acids in its cytoplasmic tail to make it resemble more closely the Vpu sensitivity motif. Surprisingly, the core components of this Vpu sensitivity sequence are also present in the host surface protein CD4, which is also targeted by Vpu through its CTD.
authors.affiliation: Department of Molecular Microbiology and Immunology, University of Missouri, Columbia, Missouri 65201, USA.
authors.forename: Sanath Kumar
authors.initials: SK
authors.lastname: Janaka
authors.forename: Tiffany M
authors.initials: TM
authors.lastname: Lucas
authors.forename: Marc C
authors.initials: MC
authors.lastname: Johnson
mesh_terms: D004252:DNA Mutational Analysis; D005622:Friend murine leukemia virus / Q000235:genetics / Q000254:growth & development; D015497:HIV-1 / Q000254:growth & development*; D054298:Human Immunodeficiency Virus Proteins / Q000378:metabolism*; D006801:Humans; D017989:Leukemia Virus, Gibbon Ape / Q000235:genetics / Q000254:growth & development*; D050505:Mutant Proteins / Q000235:genetics / Q000378:metabolism; D011995:Recombination, Genetic; D014759:Viral Envelope Proteins / Q000037:antagonists & inhibitors* / Q000235:genetics / Q000378:metabolism*; D054334:Viral Regulatory and Accessory Proteins / Q000378:metabolism*; D000086082:Viroporin Proteins
chemical_list: D054298:Human Immunodeficiency Virus Proteins; D050505:Mutant Proteins; D014759:Viral Envelope Proteins; D054334:Viral Regulatory and Accessory Proteins; C514859:vpu protein, Human immunodeficiency virus 1; D000086082:Viroporin Proteins